[HTML][HTML] Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: a large patient cohort study
Background Activated phosphoinositide 3-kinase δ syndrome (APDS) is a recently
described combined immunodeficiency resulting from gain-of-function mutations in PIK3CD …
described combined immunodeficiency resulting from gain-of-function mutations in PIK3CD …
[HTML][HTML] Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase δ syndrome 2: a cohort study
E Elkaim, B Neven, J Bruneau… - Journal of Allergy and …, 2016 - Elsevier
Background Activated phosphoinositide 3-kinase δ syndrome (APDS) 2 (p110δ-activating
mutations causing senescent T cells, lymphadenopathy, and immunodeficiency [PASLI] …
mutations causing senescent T cells, lymphadenopathy, and immunodeficiency [PASLI] …
Increased activation of PI3 kinase-δ predisposes to B-cell lymphoma
A Durandy, S Kracker - Blood, The Journal of the American …, 2020 - ashpublications.org
Abstract Activated phosphatidylinositol 3-kinase-δ (PI3K-δ) syndrome (APDS) is a rare
primary combined immunodeficiency caused by either dominant gain-of-function mutations …
primary combined immunodeficiency caused by either dominant gain-of-function mutations …
Clinical, immunological, and genetic features in patients with activated PI3Kδ syndrome (APDS): a systematic review
Activated phosphoinositide 3-kinase delta syndrome (APDS) is a novel primary
immunodeficiency (PID) caused by heterozygous gain of function mutations in PI3Kδ …
immunodeficiency (PID) caused by heterozygous gain of function mutations in PI3Kδ …
[HTML][HTML] Disease evolution and response to rapamycin in activated phosphoinositide 3-kinase δ syndrome: the european society for immunodeficiencies-activated …
ME Maccari, H Abolhassani… - Frontiers in …, 2018 - frontiersin.org
Activated phosphoinositide 3-kinase (PI3K) δ Syndrome (APDS), caused by autosomal
dominant mutations in PIK3CD (APDS1) or PIK3R1 (APDS2), is a heterogeneous primary …
dominant mutations in PIK3CD (APDS1) or PIK3R1 (APDS2), is a heterogeneous primary …
[HTML][HTML] International retrospective study of allogeneic hematopoietic cell transplantation for activated PI3K-delta syndrome
Background Activated phosphoinositide 3-kinase delta syndrome (APDS) is a combined
immunodeficiency with a heterogeneous phenotype considered reversible by allogeneic …
immunodeficiency with a heterogeneous phenotype considered reversible by allogeneic …
[HTML][HTML] Respiratory manifestations of the activated phosphoinositide 3-kinase delta syndrome
AM Condliffe, A Chandra - Frontiers in immunology, 2018 - frontiersin.org
The activated phosphoinositide 3-kinase δ syndrome (APDS), also known as p110δ-
activating mutation causing senescent T cells, lymphadenopathy, and immunodeficiency …
activating mutation causing senescent T cells, lymphadenopathy, and immunodeficiency …
Hematopoietic stem cell transplantation for progressive combined immunodeficiency and lymphoproliferation in patients with activated phosphatidylinositol-3-OH …
Background Activated phosphatidylinositol-3-OH kinase δ syndrome type 1 (APDS1) is a
recently described primary immunodeficiency syndrome characterized by recurrent …
recently described primary immunodeficiency syndrome characterized by recurrent …
Phosphatase and tensin homolog (PTEN) mutation can cause activated phosphatidylinositol 3-kinase δ syndrome–like immunodeficiency
Y Tsujita, K Mitsui-Sekinaka, K Imai, TW Yeh… - Journal of Allergy and …, 2016 - Elsevier
Background Activated phosphatidylinositol 3-kinase δ syndrome (APDS) is a recently
discovered primary immunodeficiency disease (PID). Excess phosphatidylinositol 3-kinase …
discovered primary immunodeficiency disease (PID). Excess phosphatidylinositol 3-kinase …
[HTML][HTML] Activated PI3 kinase delta syndrome: from genetics to therapy
D Michalovich, S Nejentsev - Frontiers in immunology, 2018 - frontiersin.org
Activated PI3 kinase delta syndrome (APDS) is a primary immunodeficiency caused by
dominant mutations that increase activity of phosphoinositide-3-kinase δ (PI3Kδ). APDS can …
dominant mutations that increase activity of phosphoinositide-3-kinase δ (PI3Kδ). APDS can …